Cubist Systematic Strategies, LLC Forma Therapeutics Holdings, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $391,429 - $1.11 Million	-54,976 Reduced 76.17%	17,200 $343,000
Q2 2022 Aug 15, 2022	SELL	$5.1 - $10.0 $107,456 - $210,700	-21,070 Reduced 22.6%	72,176 $497,000
Q1 2022 May 16, 2022	BUY	$8.34 - $14.69 $579,513 - $1.02 Million	69,486 Added 292.45%	93,246 $867,000
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $42,418 - $77,631	3,119 Added 15.11%	23,760 $338,000
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $244,857 - $296,552	11,539 Added 126.77%	20,641 $479,000
Q2 2021 Aug 16, 2021	BUY	$22.86 - $30.95 $208,071 - $281,706	9,102 New	9,102 $227,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.